SEARCH · Search NASA
Results for “Genetic Engineering”
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Sit Down with Sabin: Henrik Scheller: Customizing plants for biofuels. (LBNL Summer Lecture Series)
Henrik Scheller from the JBEI appeared on August 3rd, 2011 for this installment of "Sit Down with Sabin," a conversation in which former reporter Sabin Russell chats with Lab staff about innovative science. They will discuss "Customizing plants for biofuels." During this series of conversations, Russell and Lab staff will explore the ups and downs of pioneering science, all without the aid of PowerPoints.
Genetically Enhanced Sorghum and Sugarcane: Engineering Hydrocarbon Biosynthesis and Storage together with Increased Photosynthetic Efficiency into the Saccharinae
PETRO Project: UIUC is working to convert sugarcane and sorghum—already 2 of the most productive crops in the world—into dedicated bio-oil crop systems. Three components will be engineered to produce new crops that have a 50% higher yield, produce easily extractable oils, and have a wider growing range across the U.S. This will be achieved by modifying the crop canopy to better distribute sunlight and increase its cold tolerance. By directly producing oil in the shoots of these plants, these biofuels could be easily extracted with the conventional crushing techniques used today to extract sugar.
TAS::89 0227:: TAS Recovery - Recovery Act - Development of Homologous Recombination and Recombineering Technologies for Clostridial-Biotechnologies.
Explore the source record for details and available documents.
In vivo alternative assessment of the chemicals that interfere with anterior pituitary POMC expression and interrenal steroidogenesis in POMC: EGFP transgenic zebrafish
Adrenocorticotropin (ACTH) has been considered a classic adrenocorticotropic hormone and the key pituitary-derived peptide controlling steroidogenesis in the adult adrenal. ACTH is encoded by the propiomelanocortin (POMC) gene, and its active form is mainly synthesized and processed from the POMC-encoded multihormone precursor in the anterior pituitary. The ACTH level has always been precisely controlled in the signaling cascade of the hypothalamo-pituitary-adrenal (HPA) axis due to its central role. The purpose of this study was to investigate whether the transgenic zebrafish line with EGFP driven by the POMC promoter can be used as a surrogate marker to detect the interference effects on anterior pituitary POMC expression caused by chemicals in teleost. The Tg (POMC:EGFP) fish treated for 4 days with the known adrenergic agents, dexamethasone (Dex) or aminoglutethimide (AG), exhibited altered levels of EGFP and POMC expression in the anterior domain of pituitary corticotrophs. Whole-mount in situ hybridization revealed impaired patterns of expression of the zebrafish ftz-fl gene (ff1b), a key molecular marker for early interrenal development. Next, several chemicals and six commonly used organophosphorus compounds (OPs) were tested for their effects on anterior pituitary POMC expression and early interrenal development. Our preliminary screening analyses indicated that simazine and 3,3',4,4'5-pentachlorobiphenyl (PCB126) could interfere with anterior pituitary POMC expression and interrenal development in fish. In summary, our results demonstrated that the Tg (POMC:EGFP) zebrafish line might be employed as a specific and reproductive in vivo assessment model for the effects of endocrine disruption on HPA signaling.
BETO 2021 Peer Review: Algae Biotechnology Partnership - Technology Area Session: Advanced Algae Systems
Development of advanced genetic and genomic tools for targeted algal metabolic engineering pursuits will be integral to achieving target biomass productivity and, ultimately, the BETO goal of cost-competitive biofuels derived from algal biomass by 2022. However, at present, broad-host-range tool development is currently hindered by strain-specific negative regulatory mechanisms. Indeed, the biological processes controlling algal transcription and translation are subject to complex host regulation, which often presents hurdles for targeted genetic engineering strategies. Advanced genetic approaches offer a means to rewire these regulatory systems and/or introduce novel functionality into algal biocatalysts. Synthetic systems biology approaches also present a means to construct novel genetic regulatory networks and rewire natural biological systems to establish an “orthogonal central dogma,” wherein non-native control elements are introduced into or evolved in host microbes for bypass of host control. To this end, the Algae Biotechnology Partnership aims to develop advanced genetic editing tools and synthetic and orthogonal genetic regulatory systems to enable universal metabolic engineering strategies in top-candidate deployment algal strains. Successful development will ultimately open the door for targeted strain-engineering strategies, aimed at maximizing algal outdoor biomass production, composition, and strain robustness.
Application of functional genomics for domestication of novel non-model microbes
Abstract With the expansion of domesticated microbes producing biomaterials and chemicals to support a growing circular bioeconomy, the variety of waste and sustainable substrates that can support microbial growth and production will also continue to expand. The diversity of these microbes also requires a range of compatible genetic tools to engineer improved robustness and economic viability. As we still do not fully understand the function of many genes in even highly studied model microbes, engineering improved microbial performance requires introducing genome-scale genetic modifications followed by screening or selecting mutants that enhance growth under prohibitive conditions encountered during production. These approaches include adaptive laboratory evolution, random or directed mutagenesis, transposon-mediated gene disruption, or CRISPR interference (CRISPRi). Although any of these approaches may be applicable for identifying engineering targets, here we focus on using CRISPRi to reduce the time required to engineer more robust microbes for industrial applications. One-Sentence Summary The development of genome scale CRISPR-based libraries in new microbes enables discovery of genetic factors linked to desired traits for engineering more robust microbial systems.
Genetic compensation of triacylglycerol biosynthesis in the green microalga Chlamydomonas reinhardtii
Genetic compensation has been proposed to explain phenotypic differences between gene knockouts and knockdowns in several metazoan and plant model systems. With the rapid development of reverse genetic tools such as CRISPR/Cas9 and RNAi in microalgae, it is increasingly important to assess whether genetic compensation affects the phenotype of engineered algal mutants. While exploring triacylglycerol (TAG) biosynthesis pathways in the model alga Chlamydomonas reinhardtii, it was discovered that knockout of certain genes catalyzing rate-limiting steps of TAG biosynthesis, type-2 diacylglycerol acyltransferase genes (DGTTs), triggered genetic compensation under abiotic stress conditions. Genetic compensation of a DGTT1 null mutation by a related PDAT gene was observed regardless of the strain background or mutagenesis approach, for example, CRISPR/Cas 9 or insertional mutagenesis. However, no compensation was found in the PDAT knockout mutant. The effect of PDAT knockout was evaluated in a Δvtc1 mutant, in which PDAT was upregulated under stress, resulting in a 90% increase in TAG content. Knockout of PDAT in the Δvtc1 background induced a 12.8-fold upregulation of DGTT1 and a 272.3% increase in TAG content in Δvtc1/pdat1 cells, while remaining viable. These data suggest that genetic compensation contributes to the genetic robustness of microalgal TAG biosynthetic pathways, maintaining lipid and redox homeostasis in the knockout mutants under abiotic stress. This work demonstrates examples of genetic compensation in microalgae, implies the physiological relevance of genetic compensation in TAG biosynthesis under stress, and provides guidance for future genetic engineering and mutant characterization efforts.
CRISPR Tools for Engineering Prokaryotic Systems: Recent Advances and New Applications
In the past decades, the broad selection of CRISPR-Cas systems has revolutionized biotechnology by enabling multimodal genetic manipulation in diverse organisms. Rooted in a molecular engineering perspective, we recapitulate the different CRISPR components and how they can be designed for specific genetic engineering applications. We first introduce the repertoire of Cas proteins and tethered effectors used to program new biological functions through gene editing and gene regulation. We review current guide RNA (gRNA) design strategies and computational tools and how CRISPR-based genetic circuits can be constructed through regulated gRNA expression. Then, we present recent advances in CRISPR-based biosensing, bioproduction, and biotherapeutics across in vitro and in vivo prokaryotic systems. Finally, we discuss forthcoming applications in prokaryotic CRISPR technology that will transform synthetic biology principles in the near future.
Natural transformation as a tool in Acinetobacter baylyi : Streamlined engineering and mutational analysis
Natural transformation and homologous recombination in a soil bacterium, Acinetobacter baylyi ADP1, occur with exceptionally high efficiency. These genetic features can be harnessed to address a wide variety of fundamental and applied scientific topics. Recent advances in synthetic biology and laboratory evolution have led to renewed appreciation for the use of A. baylyi as a model organism. To complement several review articles that highlight new tool sets, this chapter focuses on simple protocols and examples of transformation assays that facilitate genetic analysis and engineering. Whole genome sequencing often reveals extensive genetic variation among closely related isolates that can confound the association of genotypic and phenotypic changes. In A. baylyi, such associations can be deciphered in unique ways by directly transforming cells with linear DNA fragments. The resulting allelic replacement, which occurs at high frequency, rapidly generates desired mutants via targeted chromosomal editing. Diverse screening and selection methods can be used to test hypotheses and streamline experimental strategies to reveal the significance of specific DNA sequences. Moreover, large procedural variations are well tolerated, and techniques can be readily adapted for new purposes. Furthermore, one goal of highlighting natural transformation methodology in A. baylyi is to expand the community of researchers using this versatile bacterial host.
Synthetic feed-forward loop circuit boosts transgene expression in sugarcane
Bio-based products derived from natural plant-derived materials offer a promising alternative to petroleum-based products, which are essential for achieving global sustainability (Gupta et al. 2022). Sugarcane provides 40% of the world’s biofuel (Brant et al. 2025). Recently, metabolic engineering of sugarcane for hyperaccumulation of biomass oil is emerging as a strategy to elevate the crop’s energy content (Cao et al. 2023; Maitra et al. 2024). Synthetic transcription factors offer a powerful tool for modulating entire metabolic pathways by enabling fine-tuned activation or repression of specific genes (Liu and Stewart 2016; Hooghvorst and Altpeter 2023). However, the application of these technologies faces challenges, including the availability of well-characterized genetic building blocks for precise manipulation of gene expression, and the inherently challenging properties of gene expression in highly polyploid crops like sugarcane (Liu and Stewart 2016).
Genetic-Metabolic Coupling for Targeted Metabolic Engineering
Abstract not provided
Towards engineering hybrid incompatibility in plants
The potential for gene flow between genetically modified organisms (GMOs) and non-GMO relatives poses a significant challenge to the development and regulatory approval of GMO crops (Wedger et al., 2024), for example, the spread of herbicide resistance transgenes from crops such as rice or sorghum to cross-pollinating weedy species. Addressing this concern, we developed Engineered Genetic Incompatibility (EGI) (Maselko et al., 2017), a system that establishes species-like barriers to gene flow between otherwise sexually compatible populations. EGI employs Programmable Transcriptional Activators (PTAs) to drive lethal over- and/or ectopic expression of tightly regulated genes following undesired hybridization events (Figure 1a,b). A benign mutation of the target promoter in the EGI organism protects it from ill effects of the PTA, which acts as a sentinel for the wild-type (WT) promoter sequence. Given numerous potential PTA targets, multiple mutually incompatible subpopulations are feasible (Maselko et al., 2020). EGI has been demonstrated in yeast as a proof-of-concept (Maselko et al., 2017) and in insects as a strategy for genetic biocontrol of pests (Maselko et al., 2020; Upadhyay et al., 2022). EGI in plants would provide a strategy to halt gene flow between engineered crops and their domestic and wild relatives without altering normal cultivation or propagation practices. Here, we present promising results towards the demonstration of EGI in plants and highlight technical challenges that still need to be overcome.
Production and Engineering of Hydrogenase as a Biocatalyst for Hydrogen Fuel
Hydrogenases are fascinating redox proteins, showing tremendous promise in the utilization of hydrogen fuel as a bioelectrocatalyst. They play critical roles in both biohydrogen production and hydrogen oxidation. Specifically, the recently-established comparability of the oxidative activity of the [NiFe]-hydrogenase active site to that of the fuel cell catalyst platinum marks a significant milestone for the potential application of hydrogenase in hydrogen fuel cells to replace platinum. However, the ability of producing hydrogenase in heterologous expression hosts and the sensitivity of hydrogenases to oxygen and carbon monoxide, etc. have seriously limited the viable macroscale utilization and production of hydrogen from the renewable source. A new technology for the production of up-take hydrogenase is being developed for the utilization of hydrogenase as a hydrogen catalyst. The development of this new technology integrates knowledge of structural biology, molecular biology, and principles of metabolic engineering to produce and engineer a stable hydrogenase as a hydrogen bioelectrocatalyst. It contributes to the critical issues of “expensive noble metal catalysts (i.e., platinum) and their limited reserves threatening the long-term sustainability of a hydrogen economy”. It also provides a model to “design natural materials and enzyme catalyst” for “efficient and cost-effective technologies” for a clean and sustainable energy in 21 st century. This new technology includes 3 major components. The first component is the synthetic operons, which carry hydrogenase maturation pathways of Ralstonia eutropha. These synthetic operons are engineered to produce RH hydrogenase in the Escherichia coli strains based on our current molecular and genetic information of hydrogenase maturation mechanisms and pathways of R. eutropha. It presents the first example of producing hydrogenase in the conventional expression host using synthetic biology principles and tool kits. For the high-yield production of the hydrogenase, protein degradation pathways are altered to prevent hydrogenase degradation. This part of the new technology provides a frame work for the design of hydrogenase production pathways for desirable bioengineering purposes. The results of this work are significantly beneficial to research in the areas of enzyme fuel cells, bioelectrocatalyst production, and biohydrogen production as well as basic research in hydrogenase structure biology. The second component of the new technology includes the stable hydrogenase with the improved electrochemical and catalytic properties. With the guidance of the current information on [NiFe] hydrogenase structure, hydrogenase mutants and mutant libraries are generated using protein engineering approaches. The resulting mutants are screened for better hydrogenase stability and catalytic activities. This part of the research results in the identification of new hydrogenase mutants with improved catalytic properties, which can be used for the future studies on enzyme full cells and the catalytic mechanism of hydrogenase. The third component is the optimized production of the selected hydrogenase mutant using current fermentation and metabolic engineering strategies. Metabolic burdens and biomass is balanced using different induction conditions for the optimum production of the engineered hydrogenase in genetically engineered E. coli strains. The success of this work presents a good example of the application of modern fermentation technologies in bioelectrocatalyst production.
Tissue-engineered human bioartificial muscles expressing a foreign recombinant protein for gene therapy
Murine skeletal muscle cells transduced with foreign genes and tissue engineered in vitro into bioartificial muscles (BAMs) are capable of long-term delivery of soluble growth factors when implanted into syngeneic mice (Vandenburgh et al., 1996b). With the goal of developing a therapeutic cell-based protein delivery system for humans, similar genetic tissue-engineering techniques were designed for human skeletal muscle stem cells. Stem cell myoblasts were isolated, cloned, and expanded in vitro from biopsied healthy adult (mean age, 42 +/- 2 years), and elderly congestive heart failure patient (mean age, 76 +/- 1 years) skeletal muscle. Total cell yield varied widely between biopsies (50 to 672 per 100 mg of tissue, N = 10), but was not significantly different between the two patient groups. Percent myoblasts per biopsy (73 +/- 6%), number of myoblast doublings prior to senescence in vitro (37 +/- 2), and myoblast doubling time (27 +/- 1 hr) were also not significantly different between the two patient groups. Fusion kinetics of the myoblasts were similar for the two groups after 20-22 doublings (74 +/- 2% myoblast fusion) when the biopsy samples had been expanded to 1 to 2 billion muscle cells, a number acceptable for human gene therapy use. The myoblasts from the two groups could be equally transduced ex vivo with replication-deficient retroviral expression vectors to secrete 0.5 to 2 microg of a foreign protein (recombinant human growth hormone, rhGH)/10(6) cells/day, and tissue engineered into human BAMs containing parallel arrays of differentiated, postmitotic myofibers. This work suggests that autologous human skeletal myoblasts from a potential patient population can be isolated, genetically modified to secrete foreign proteins, and tissue engineered into implantable living protein secretory devices for therapeutic use.
Xylitol synthesis mutant of xylose-utilizing zymomonas for ethanol production
A strain of xylose-utilizing Zymomonas was engineered with a genetic modification to the glucose-fructose oxidoreductase gene resulting in reduced expression of GFOR enzyme activity. The engineered strain exhibits reduced production of xylitol, a detrimental by-product of xylose metabolism. It also consumes more xylose and produces more ethanol during mixed sugar fermentation under process-relevant conditions.
NREL Advancements in Methane Conversion Lead to Cleaner Air, Useful Products
Researchers at NREL leveraged the recent on-site development of gas fermentation capabilities and novel genetic tools to directly convert methane to lactic acid using an engineered methanotrophic bacterium. The results provide proof-of-concept data for a gas-to-liquids bioprocess that concurrently produces fuels and chemicals from methane. NREL researchers developed genetic tools to express heterologous genes in methanotrophic organisms, which have historically been difficult to genetically engineer. Using these tools, researchers demonstrated microbial conversion of methane to lactate, a high-volume biochemical precursor predominantly utilized for the production of bioplastics. Methane biocatalysis offers a means to concurrently liquefy and upgrade natural gas and renewable biogas, enabling their utilization in conventional transportation and industrial manufacturing infrastructure. Producing chemicals and fuels from methane expands the suite of products currently generated from biorefineries, municipalities, and agricultural operations, with the potential to increase revenue and significantly reduce greenhouse gas emissions.
Reassessing the Progress in the Production of Advanced Biofuels in the Current Competitive Environment and Beyond: What Are the Successes and Where Progress Eludes Us and Why
The concept, science, and technology of biofuels has captured the public’s imagination as well as the attention of the academic and industrial R&D communities over the last 10 years. The 2006 US DOE report has been the basis for funding three US Bioenergy Centers, and has precipitated increased research funding worldwide. Despite the large funding resources, there is little evidence to support that processes for advanced biofuels (i.e., fuel molecules more dense than ethanol) are anywhere near achieving economic feasibility. In assessing the current status of the field for biology-based processes, there has been tremendous progress in metabolic and pathway engineering and the development of synthetic-biology tools that can be applied to engineer strains. Furthermore, the economic feasibility of what is currently possible remains in doubt, especially in light of the recent low prices of oil and natural gas. Issues liming the economic feasibility are assessed and strategies to take advantage of the successful achievements are suggested. Analysis suggests that for biofuel molecules larger than four carbons, purely biological processes cannot be currently justified, but hybrid biological/catalytic technologies may offer the necessary economies to produce such biofuels.